The Siesta Group Schlafanalyse
The Siesta Group Schlafanalyse is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Efficacy and tolerability of tasipimidine after 3 repeated bed-time doses in patients with insomnia disorder with a 4-week extension part
Sponsor Orion Corporation
- Start (EU)
- Latest update
- Estimated end
Operational learnings available3 trial-level findings · Read insights
- Protocol Amendment 2 extended the trial period and increased the number of sites.
- Protocol Amendment 4 extended Part 2 treatment from 3 days in a sleep laboratory to a 4-week period in the sleep laboratory and at home.
- Part 3 was not started because the interim analysis of Parts 1 and 2 showed no significant primary-endpoint efficacy for any tasipimidine dose versus placebo.
These findings describe the trial, not the service provider’s performance or responsibility.
Efficacy and safety of NNC0487-0111 s.c. once-weekly in participants with overweight or obesity, and obstructive sleep apnoea not treated with positive airway pressure (AMAZE 3)
Sponsor Novo Nordisk A/S
- Start (EU)
- Latest update
- Estimated end
Efficacy and safety of NNC0487-0111 s.c. once-weekly in participants with overweight or obesity, and obstructive sleep apnoea treated with positive airway pressure (AMAZE 4)
Sponsor Novo Nordisk A/S
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for The Siesta Group Schlafanalyse?
The 2026-10-09 snapshot links The Siesta Group Schlafanalyse to 3 distinct CTIS trials. Recorded services include Polysomnography (PSG), Polysomnography analysis. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for The Siesta Group Schlafanalyse?
The most frequently recorded therapeutic areas are Endocrinology, Metabolic Disorders, Respiratory, Neurology. Recorded phases include Phase 3, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to The Siesta Group Schlafanalyse conducted?
The linked trials record locations in 5 countries, including Germany, Poland, Spain, Denmark, Finland. These are trial locations, not confirmed office locations or countries where The Siesta Group Schlafanalyse delivered services.
What can this page tell me about The Siesta Group Schlafanalyse's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under The Siesta Group Schlafanalyse. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- The Siesta Group Schlafanalyse GmbH